Plantable Health Inc.
PLBL.NE · NEO
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | CA$1,203 | CA$1,119 | CA$1,141 | CA$978 |
| % Growth | 7.5% | -1.9% | 16.7% | – |
| Cost of Goods Sold | CA$912 | CA$937 | CA$924 | CA$940 |
| Gross Profit | CA$291 | CA$183 | CA$217 | CA$38 |
| % Margin | 24.2% | 16.3% | 19% | 3.9% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$2,437 | CA$1,407 | CA$597 | CA$111 |
| SG&A Expenses | CA$3,182 | CA$1,575 | CA$692 | CA$764 |
| Sales & Mktg Exp. | CA$746 | CA$168 | CA$95 | CA$266 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$3,211 | CA$1,586 | CA$588 | CA$1,014 |
| Operating Income | -CA$2,958 | -CA$1,406 | -CA$368 | -CA$733 |
| % Margin | -245.8% | -125.6% | -32.2% | -74.9% |
| Other Income/Exp. Net | -CA$83 | -CA$3,201 | -CA$9 | -CA$292 |
| Pre-Tax Income | -CA$3,023 | -CA$4,605 | -CA$488 | -CA$1,025 |
| Tax Expense | CA$8 | CA$0 | CA$221 | CA$0 |
| Net Income | -CA$3,023 | -CA$4,605 | -CA$488 | -CA$1,025 |
| % Margin | -251.2% | -411.4% | -42.8% | -104.8% |
| EPS | -0.048 | -0.073 | -0.008 | -0.014 |
| % Growth | 34.3% | -845.5% | 45% | – |
| EPS Diluted | -0.048 | -0.073 | -0.008 | -0.014 |
| Weighted Avg Shares Out | 63,250 | 63,250 | 63,250 | 73,000 |
| Weighted Avg Shares Out Dil | 63,250 | 63,250 | 63,250 | 73,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$3 | CA$49 |
| Interest Expense | CA$8 | CA$63 | CA$221 | CA$0 |
| Depreciation & Amortization | CA$117 | CA$114 | CA$114 | CA$94 |
| EBITDA | -CA$2,841 | -CA$1,292 | -CA$254 | -CA$639 |
| % Margin | -236.1% | -115.4% | -22.3% | -65.3% |